Xponance Inc. decreased its stake in shares of Adient plc (NYSE:ADNT – Free Report) by 19.3% during the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 12,225 shares of the company’s stock after selling 2,930 shares during the quarter. Xponance Inc.’s holdings in Adient were worth $302,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. Magnetar Financial LLC increased its holdings in shares of Adient by 30.1% during the 2nd quarter. Magnetar Financial LLC now owns 108,535 shares of the company’s stock worth $2,682,000 after purchasing an additional 25,119 shares during the period. Barrow Hanley Mewhinney & Strauss LLC increased its holdings in shares of Adient by 1.1% during the 2nd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 1,616,457 shares of the company’s stock worth $39,943,000 after purchasing an additional 17,833 shares during the period. Sei Investments Co. increased its holdings in shares of Adient by 26.5% during the 2nd quarter. Sei Investments Co. now owns 64,752 shares of the company’s stock worth $1,600,000 after purchasing an additional 13,546 shares during the period. XTX Topco Ltd increased its holdings in shares of Adient by 98.6% during the 2nd quarter. XTX Topco Ltd now owns 29,579 shares of the company’s stock worth $731,000 after purchasing an additional 14,686 shares during the period. Finally, Seven Eight Capital LP boosted its position in shares of Adient by 273.0% during the 2nd quarter. Seven Eight Capital LP now owns 89,392 shares of the company’s stock valued at $2,209,000 after acquiring an additional 65,424 shares in the last quarter. Institutional investors own 92.44% of the company’s stock.
Adient Price Performance
ADNT opened at $22.34 on Wednesday. Adient plc has a one year low of $19.40 and a one year high of $37.19. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.08 and a quick ratio of 0.87. The company’s 50 day simple moving average is $22.38 and its 200-day simple moving average is $26.16. The stock has a market capitalization of $2.01 billion, a P/E ratio of 13.71, a price-to-earnings-growth ratio of 0.59 and a beta of 2.16.
Wall Street Analysts Forecast Growth
ADNT has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $24.00 target price on shares of Adient in a research report on Tuesday, September 10th. Morgan Stanley decreased their target price on shares of Adient from $32.00 to $21.00 and set an “underweight” rating on the stock in a research report on Wednesday, August 14th. Wells Fargo & Company decreased their target price on shares of Adient from $29.00 to $27.00 and set an “overweight” rating on the stock in a research report on Friday, September 20th. BNP Paribas upgraded shares of Adient from an “underperform” rating to a “neutral” rating and set a $26.00 target price on the stock in a research report on Monday, July 1st. Finally, Wolfe Research assumed coverage on shares of Adient in a research report on Thursday, September 5th. They issued a “peer perform” rating on the stock. One research analyst has rated the stock with a sell rating, seven have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $26.63.
Read Our Latest Stock Analysis on ADNT
Adient Company Profile
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Read More
- Five stocks we like better than Adient
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Options Trading – Understanding Strike Price
- 2 Energy Stocks Fueling the AI Datacenter Boom
- High Flyers: 3 Natural Gas Stocks for March 2022
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Want to see what other hedge funds are holding ADNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adient plc (NYSE:ADNT – Free Report).
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.